Azomax Medicine Alert 2026: Medicines Verification in Pakistan with VeriDoc Global

What Happened?

The recent alert issued by the Drug Regulatory Authority of Pakistan (DRAP) identified a falsified batch of Azomax 250mg Tablets (Azithromycin) circulating within the pharmaceutical supply chain.

According to the published alert, the affected product was associated with Batch No. H5332 with an expiry date of July 2027.

As a precaution, DRAP advised manufacturers, distributors, pharmacies, healthcare professionals, and the public to immediately stop distributing or using the affected batch and to report any suspected stock through the appropriate regulatory channels.

While this alert focuses on one specific medicine, it also exposes a much larger issue facing healthcare systems worldwide:

How can every medicine be independently verified before it reaches a patient?

Why Falsified Medicines Are Such a Serious Risk

Unlike medicines that are simply damaged or expired, falsified medicines are deliberately designed to appear genuine.

They may copy legitimate packaging, branding, batch numbers, or product information, making them extremely difficult to identify through visual inspection alone.

The consequences can be severe.

• Patients may receive ineffective treatment.

• Healthcare professionals may unknowingly prescribe medicines that do not perform as expected.

• Pharmacies risk losing customer trust.

• Manufacturers face damage to their reputation despite having no involvement in producing the falsified products.

• For regulators, every falsified medicine represents a potential public health emergency.

The Challenge Isn’t Just Manufacturing, It’s Verification

Pharmaceutical companies invest heavily in quality control, manufacturing standards, and regulatory compliance before medicines leave the production facility.

However, once products begin moving through wholesalers, distributors, pharmacies, hospitals, and healthcare providers, verifying authenticity becomes much more difficult.

Today, most people still rely on visual checks.

• Does the packaging look genuine?

• Does the label appear correct?

• Is the expiry date printed properly?

Unfortunately, modern falsified medicines can closely resemble authentic products, making visual inspection alone an unreliable method of verification.

The Need for Smarter Medicine Verification

Imagine if every medicine package could be independently verified in just a few seconds.

Instead of relying only on appearance, pharmacists, distributors, hospitals, regulators and even patients could instantly confirm whether a medicine matches its original authenticated record.

This would provide an additional layer of confidence before medicines are dispensed or consumed.

Rather than replacing existing pharmaceutical regulations, digital verification strengthens them by making authenticity easier to confirm throughout the supply chain.

How VeriDoc Global Can Help Strengthen Medicine Verification

VeriDoc Global provides a secure pharmaceutical verification platform that helps protect medicines from the moment they leave the manufacturer until they reach the patient.

The process begins during manufacturing.

Once a medicine has successfully completed quality assurance and is approved for distribution, the manufacturer generates a secure digital record containing the authorised product information. This can include details such as the product name, batch number, manufacturing date, expiry date, packaging information, and other approved production data.

Rather than storing this information in a way that could be easily altered, VeriDoc Global first processes the authorised data using the SHA-256 cryptographic hashing algorithm. This creates a unique digital fingerprint of the medicine’s original information.

That fingerprint is then securely recorded on the VeriDoc Ledger, creating a permanent, blockchain-backed verification record that cannot be secretly modified or replaced. Importantly, the blockchain stores the verification record not the medicine itsel —helping maintain both security and data integrity.

A unique QR code is then printed directly onto the medicine packaging during production. This QR code acts as a secure link between the physical medicine and its trusted digital verification record.

As the medicine moves through manufacturers, distributors, wholesalers, pharmacies, hospitals, and finally to patients, anyone authorised to verify the product can simply scan the QR code using a smartphone or compatible scanning device.

Instead of displaying only basic product information, VeriDoc Global compares the scanned product against its original blockchain-backed verification record stored within the VeriDoc Ledger.

If everything matches, the system confirms that the medicine is genuine and that its critical product information has not been altered since it was issued by the manufacturer.

If discrepancies are detected such as altered product details, manipulated packaging information, or attempts to replicate a genuine product the system immediately alerts the user that the medicine requires further investigation before it is dispensed or supplied.

This creates a trusted verification process throughout the entire pharmaceutical supply chain. Manufacturers gain stronger protection for their brands, distributors and pharmacies can verify stock before supplying it, regulators have greater confidence during inspections, healthcare professionals can confirm medicine authenticity, and patients receive an additional layer of assurance that the medicine they are taking is genuine.

Rather than replacing existing pharmaceutical manufacturing or regulatory processes, VeriDoc Global adds an independent layer of digital trust that strengthens medicine verification from production through to patient care.

Protecting Every Stage of the Pharmaceutical Supply Chain

Medicine verification isn’t only valuable for manufacturers.

It benefits every organisation involved in delivering medicines safely.

Pharmaceutical Manufacturers can better protect their brands and reduce the impact of falsified products.

Distributors and Wholesalers can verify product authenticity before medicines continue through the supply chain.

Hospitals and Pharmacies gain greater confidence that medicines being supplied to patients are genuine.

Patients benefit from increased confidence that the medicines they receive come from legitimate and trusted sources.

When every participant can verify authenticity, the entire supply chain becomes stronger.

Lessons From the Azomax Alert

The recent Azomax incident is about more than a single medicine.

It demonstrates why healthcare systems around the world need stronger verification processes.

As falsified medicines become increasingly sophisticated, relying solely on packaging, printed labels, or manual inspections will become progressively more difficult.

Digital verification provides an additional safeguard that helps protect public health while supporting manufacturers, healthcare providers, and regulators.

The goal isn’t simply to identify falsified medicines after they enter the market.

It’s to make verifying genuine medicines easier before they reach patients.

Looking Ahead

The pharmaceutical industry is rapidly embracing digital technologies to improve patient safety, strengthen supply chain visibility, and reduce fraud.

Medicine verification will play an increasingly important role in this transformation.

Organisations that invest in trusted verification technologies today will be better prepared to protect patients, support regulatory compliance, and strengthen confidence in their products tomorrow.

Final Thoughts

The recent Azomax falsified medicine alert serves as an important reminder that medicine authenticity cannot rely on appearance alone.

As pharmaceutical supply chains continue to evolve, secure verification will become an essential part of protecting patients and maintaining trust across the healthcare ecosystem.

VeriDoc Global helps strengthen medicine verification by enabling manufacturers, regulators, healthcare providers, pharmacies, distributors, and patients to confirm the authenticity of pharmaceuticals.